ArticleJournal of translational medicine2025

Baseline serum EV-miR-1-3p as a protective factor and biomarker for hepatocellular carcinoma development after HCV eradication.

Wei Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.